BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19687424)

  • 1. Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease.
    Clark J; Yao L; Pavletic SZ; Krumlauf M; Mitchell S; Turner ML; Cowen EW
    Arch Dermatol; 2009 Aug; 145(8):918-22. PubMed ID: 19687424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous Chronic Graft Versus Host Disease Following Allogeneic Haematopoietic Stem Cell Transplantation in Children: A Retrospective Study.
    Shreberk-Hassidim R; Neumark M; Greenberger S; Goldstein G; Hassidim A; Dukler Y; Maly A; Stepensky P; Molho-Pessach V
    Acta Derm Venereol; 2018 Feb; 98(2):206-211. PubMed ID: 29057425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft versus host disease-related eosinophilic fasciitis: cohort description and literature review.
    Hidalgo Calleja C; Martín Hidalgo D; Román Curto C; Vázquez López L; Pérez López E; Cabrero Calvo M; Martín López AÁ; Caballero Barrigón MD; Lopez-Corral L
    Adv Rheumatol; 2022 Aug; 62(1):33. PubMed ID: 35999577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease.
    Cardones AR; Sullivan KM; Green C; Chao NJ; Rowe-Nichols K; Bañez LL; Burton CS; Horwitz ME; Long GD; Rao CL; Sarantopoulos S; Sidhu-Malik N; Sung AD; Hall RP
    JAMA Dermatol; 2019 Jul; 155(7):833-837. PubMed ID: 30994873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease.
    Baumrin E; Baker LX; Byrne M; Martin PJ; Flowers ME; Onstad L; El Jurdi N; Chen H; Beeghly-Fadiel A; Lee SJ; Tkaczyk ER
    JAMA Dermatol; 2023 Apr; 159(4):393-402. PubMed ID: 36884224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidity.
    Jachiet M; de Masson A; Peffault de Latour R; Rybojad M; Robin M; Bourhis JH; Xhaard A; Dhedin N; Sicre de Fontbrune F; Suarez F; Barete S; Parquet N; Nguyen S; Ades L; Rubio MT; Wittnebel S; Bagot M; Socié G; Bouaziz JD
    Br J Dermatol; 2014 Jul; 171(1):63-8. PubMed ID: 24404963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic graft-versus-host disease presenting as eosinophilic fasciitis: therapeutic challenges and an additional case.
    Ganta CC; Chatterjee S; Pohlman B; Hojjati M
    J Clin Rheumatol; 2015 Mar; 21(2):86-94. PubMed ID: 25710860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host Disease.
    Gandelman JS; Zic J; Dewan AK; Lee SJ; Flowers M; Cutler C; Pidala J; Chen H; Jagasia MH; Tkaczyk ER
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):279-286. PubMed ID: 30219700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic risk factors for sclerotic graft-versus-host disease.
    Inamoto Y; Martin PJ; Flowers ME; Lee SJ; Carpenter PA; Warren EH; Geraghty DE; Lee N; Boeckh MJ; Storer BE; Levine DM; Fan W; Zhao LP; Hansen JA
    Blood; 2016 Sep; 128(11):1516-24. PubMed ID: 27313329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical Scleroderma-like Chronic GVHD in a Liver Transplant Patient, Clinical and MRI Correlations.
    Giannoni M; Rizzetto G; Diotallevi F; Molinelli E; Radi G; Campanati A; Brancorsni D; Offidani A
    Acta Dermatovenerol Croat; 2022 Sep; 30(2):123-125. PubMed ID: 36254548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses.
    Martires KJ; Baird K; Citrin DE; Hakim FT; Pavletic SZ; Cowen EW
    Arch Dermatol; 2011 Sep; 147(9):1081-6. PubMed ID: 21931046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral chronic graft-vs.-host disease characterization using the NIH scale.
    Fassil H; Bassim CW; Mays J; Edwards D; Baird K; Steinberg SM; Williams KM; Cowen EW; Mitchell SA; Hakim FT; Taylor T; Avila D; Zhang D; Grkovic L; Datiles M; Gress RE; Pavletic SZ
    J Dent Res; 2012 Jul; 91(7 Suppl):45S-51S. PubMed ID: 22699667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods to Assess Disease Activity and Severity in Cutaneous Chronic Graft-versus-Host Disease: A Critical Literature Review.
    Shakshouk H; Tkaczyk ER; Cowen EW; El-Azhary RA; Hashmi SK; Kenderian SJ; Lehman JS
    Transplant Cell Ther; 2021 Sep; 27(9):738-746. PubMed ID: 34107339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic cutaneous graft-versus-host disease in children: A report of 14 patients from a tertiary care pediatric dermatology clinic.
    Nanda A; Husain MAA; Al-Herz W; Almekaimi A; Al-Sabah H; Al-Otaibi M
    Pediatr Dermatol; 2018 May; 35(3):343-353. PubMed ID: 29536565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genital chronic GVHD in men after hematopoietic stem cell transplantation: a single-center cross-sectional analysis of 155 patients.
    Mueller SM; Haeusermann P; Rovó A; Halter JP; Passweg J; Itin P; Tichelli A
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1574-80. PubMed ID: 23962394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease.
    Hillen U; Häusermann P; Massi D; Janin A; Wolff D; Lawitschka A; Greinix H; Meyer R; Ziemer M
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):948-54. PubMed ID: 25265987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation-a retrospective analysis on seven patients.
    Lamby P; Wolff D; Mielke S; Grigoleit GU; Ljungman P; Hilgendorf I; Holler E; Holler B; Weber D; Herr W; Schiltz D; Klein S; Graf S; Bjornhagen-Safwenberg V; Dolderer J; Prantl L
    Ann Hematol; 2019 Aug; 98(8):1867-1875. PubMed ID: 30993415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
    Kattner AS; Holler E; Holler B; Klobuch S; Weber D; Martinovic D; Edinger M; Herr W; Wolff D
    Ann Hematol; 2020 Apr; 99(4):847-853. PubMed ID: 32086584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral disease profiles in chronic graft versus host disease.
    Bassim CW; Fassil H; Mays JW; Edwards D; Baird K; Steinberg SM; Cowen EW; Naik H; Datiles M; Stratton P; Gress RE; Pavletic SZ
    J Dent Res; 2015 Apr; 94(4):547-54. PubMed ID: 25740857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nail dystrophy, edema, and eosinophilia: harbingers of severe chronic GVHD of the skin in children.
    Huang JT; Duncan CN; Boyer D; Khosravi H; Lehmann LE; Saavedra A
    Bone Marrow Transplant; 2014 Dec; 49(12):1521-7. PubMed ID: 25243619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.